Table 1

Baseline characteristics, clinical presentation, and outcome of diabetic patients with controlled or uncontrolled glycemia
Controlled glycemia (n = 19) Uncontrolled glycemia (n = 83) p value p value, (adjusted age)
Male 12 (63.2) 59 (71.1) 0.498 0.952
Age in years 70.6 ± 9.6 62.8 ± 14.9 0.017
Underlying diseases
 Malignancy 1 (5.6) 10 (12.7) 0.683 0.367
 Alcoholism 1 (5.3) 4 (4.8) 1.000 0.655
 Chronic kidney disease 1 (5.6) 8 (10.3) 1.000 0.311
 Liver cirrhosis 0 (0) 2 (2.4) 1.000 0.494
 Congestive heart failure 0 (0) 2 (2.4) 1.000 0.392
 Chronic lung disease 0 (0) 1 (1.2) 1.000 0.549
Newly diagnosed diabetes 4 (21.1) 21 (25.3) 1.000 0.995
Origin
 Cryptogenic 15 (78.9) 77 (92.8) 0.087 0.090
 Biliary tract origin 1 (5.3) 5 (6.0) 1.000 0.785
Abscess locations
 Right lobe 11 (57.9) 44 (53.0) 0.791 0.407
 Left lobe 5 (26.3) 19 (22.9)
 Both lobes 3 (15.8) 20 (24.1)
Abscess size
 < 5 cm 9 (47.4) 36 (43.4) 1.000 0.707
 5 ~ 10 cm 9 (47.4) 39 (47.0)
 >; 10 cm 1 (5.3) 8 (9.6)
Gas forming 0 (0) 12 (14.5) 0.116 0.126
Multiple abscesses 8 (42.1) 29 (34.9) 0.558 0.791
Initial laboratory value
 Leukocyte count, × 103/μL 12.4 ± 3.8 13.5 ± 6.0 0.165 0.417
 Platelet, × 103/μL 195 ± 87 229 ± 121 0.145 0.442
 C-reactive protein, mg/dL 18.8 ± 9.2 20.0 ± 9.8 0.487 0.779
 Glucose, mg/dL 193 ± 76 318 ± 168 0.007 0.004
Treatment
 Antibiotics + drainage 16 (84.2) 69 (83.1) 1.000 0.894
 Antibiotics + operation 1 (5.3) 3 (3.6) 0.568 0.525
 Antibiotics only 2 (10.5) 11 (13.4) 1.000 0.557
Metastatic infections 0 (0) 12 (14.5) 0.116 0.077
Outcome
 Hospitalization days 26.2 ± 12.1 28.1 ± 19.0 0.692 0.428
 Intensive care unit admission 2 (10.5) 12 (14.5) 1.000 0.849
 Mortality 0 (0) 3 (3.6) 1.000 0.359

Data are presented as mean ± SD or frequency with percentage (%).

Lin et al.

Lin et al. BMC Infectious Diseases 2013 13:56   doi:10.1186/1471-2334-13-56

Open Data